HomeMost PopularTech Stocks New Strong Buy Stocks for February 14th Unearthing Unmissable Investment Opportunities: The Top...

New Strong Buy Stocks for February 14th Unearthing Unmissable Investment Opportunities: The Top Strong Buy Stocks for February 14th

Daily Market Recaps (no fluff)

always free

Here’s a selection of five stocks added to the prestigious Zacks Rank #1 (Strong Buy) List today:

Galecto, Inc. GLTO: The Zacks Consensus Estimate for this biotechnology firm’s current year earnings has surged by 4.9% over the last 60 days.

Galecto, Inc. Performance and Outlook

Galecto, Inc. Price and Consensus

Explore Galecto, Inc.’s price-consensus-chart | Galecto, Inc. Quote

Lumen Technologies, Inc. LUMN: This facilities-based technology and communications company has witnessed a 16.7% increase in the Zacks Consensus Estimate for its current year earnings over the last 60 days.

Lumen Technologies, Inc. Performance and Outlook

Lumen Technologies, Inc. Price and Consensus

View Lumen Technologies, Inc.’s price-consensus-chart | Lumen Technologies, Inc. Quote

Morphic Holding, Inc. MORF: The Zacks Consensus Estimate for this biopharmaceutical company’s current year earnings has risen by 3.4% over the last 60 days.

Morphic Holding, Inc. Performance and Outlook

Morphic Holding, Inc. Price and Consensus

Check out Morphic Holding, Inc.’s price-consensus-chart | Morphic Holding, Inc. Quote

Southern First Bancshares, Inc. SFST: The Zacks Consensus Estimate for this bank holding company’s current year earnings has climbed by 13% over the last 60 days

Southern First Bancshares, Inc. Performance and Outlook

Southern First Bancshares, Inc. Price and Consensus

Examine Southern First Bancshares, Inc.’s price-consensus-chart | Southern First Bancshares, Inc. Quote

Stoke Therapeutics, Inc. STOK: The Zacks Consensus Estimate for this biopharmaceutical company’s current year earnings has grown by 4.4% over the last 60 days.

Stoke Therapeutics, Inc. Performance and Outlook

Stoke Therapeutics, Inc. Price and Consensus

Review Stoke Therapeutics, Inc.’s price-consensus-chart | Stoke Therapeutics, Inc. Quote

To peruse the complete list of today’s Zacks #1 Rank (Strong Buy) stocks, click here. 

Zacks Reveals ChatGPT “Sleeper” Stock

Delve into the extraordinary world of the Artificial Intelligence sector with Zacks, as it unearths a company positioned to make a colossal economic impact, rivaling that of the internet and iPhone by 2030 – estimated at a staggering $15.7 Trillion.

Zacks is providing a complimentary report, revealing this groundbreaking growth stock and four other essential investment opportunities.

Download the Free ChatGPT Stock Report Now >>

Stay updated with the latest recommendations from Zacks Investment Research with the 7 Best Stocks for the Next 30 Days. Click here for the free report

Southern First Bancshares, Inc. (SFST) : Free Stock Analysis Report

Stoke Therapeutics, Inc. (STOK) : Free Stock Analysis Report

Morphic Holding, Inc. (MORF) : Free Stock Analysis Report

Lumen Technologies, Inc. (LUMN) : Free Stock Analysis Report

Galecto, Inc. (GLTO) : Free Stock Analysis Report

Read this article on Zacks.com by clicking here.

Zacks Investment Research

The author’s views and opinions expressed herein do not necessarily reflect those of Nasdaq, Inc.

Do you want a daily market summary with no fluff?

Simple Straightforward Daily Stock Market Recaps Sent for free,every single trading day: Read Now

Explore More

Simple Straightforward Daily Stock Market Recaps

Get institutional-level analysis to take your trading to the next level, sign up for free and become apart of the community.